Erratum: The spectrum of disease in chronic traumatic encephalopathy (Brain (2013) 136:1 (43-64) DOI:10.1093/brain/aws307);The spectrum of disease in chronic traumatic encephalopathy

Brain

Volumn 136, Issue 1, 2013, Pages 43-64

  McKee, Ann C ^a,b   Stein, Thor D ^a,b   Nowinski, Christopher J ^b,c   Stern, Robert A ^b   Daneshvar, Daniel H ^b   Alvarez, Victor E ^b   Lee, Hyo Soon ^b   Hall, Garth ^d   Wojtowicz, Sydney M ^a,b   Baugh, Christine M ^b   Riley, David O ^b   Kubilus, Caroline A ^b   Cormier, Kerry A ^a   Jacobs, Matthew A ^b   Martin, Brett R ^e   Abraham, Carmela R ^b   Ikezu, Tsuneya ^b   Reichard, Robert Ross ^f   Wolozin, Benjamin L ^b   Budson, Andrew E ^a,b   Goldstein, Lee E ^b,f   Kowall, Neil W ^a,b   Cantu, Robert C ^b,c,g   more..

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sports Legacy Institute   (United States)

^d University of Massachusetts Lowell   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f MAYO CLINIC   (United States)

^g EMERSON HOSPITAL   (United States)

Author keywords

axonal injury; brain trauma; frontotemporal lobar degeneration; neurodegenerative disorders; traumatic brain injury

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

ADOLESCENT; ADULT; AGED; AGGRESSION; ALZHEIMER DISEASE; AMNESIA; ARTICLE; ATHLETE; ATTENTION DISTURBANCE; AUTOMUTILATION; AUTOPSY; CHRONIC BRAIN DISEASE; CHRONIC TRAUMATIC ENCEPHALOPATHY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DNA BINDING; EXECUTIVE FUNCTION; FOOTBALL; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; HEADACHE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; NERVE FIBER; NEURITE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECURRENT DISEASE; TAUOPATHY; TEMPORAL LOBE; TRAUMATIC BRAIN INJURY; VETERAN; WHITE MATTER;

EID: 84873352895     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt051     Document Type: Erratum

References (81)

1. Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc Natl Acad Sci USA 2006; 103: 2892-7.
2. Anthony IC, Norrby KE, Dingwall T, Carnie FW, Millar T, Arango JC, et al. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain 2010; 133: 3685-98.
3. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631-9.
4. Baugh CM, Stamm JM, Riley DO, Gavett BE, Shenton ME, Lin A, et al. Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav 2012; 2: 244-54.
5. Bigio EH. Update on recent molecular and genetic advances in FTLD. J Neuropathol Exp Neurol 2008; 67: 635-48.
6. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
7. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993; 33: 403-8.
8. Braak H, Braak E. Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 1994; 15: 355-6.
9. Braak H, Del Tredici K. Nervous system pathology in sporadic Parkinson disease. Neurology 2008; 70: 1916-25.
10. Braak H, Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 2011; 121: 171-81.
11. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci 1994; 124: 96-107.
12. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-9.
13. Brown LM, Schinka JA. Development and initial validation of a 15-item informant version of the Geriatric Depression Scale. Int J Geriatr Psychiatry 2005; 20: 911-8.
14. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for FTLD: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007; 114: 5-22.
15. Chen LJ, Wang YJ, Tseng GF. Compression alters kinase and phosphat-ase activity and tau and MAP2 phosphorylation transiently while inducing the fast adaptive dendritic remodeling of underlying cortical neurons. J Neurotrauma 2010; 27: 1657-69.
16. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 11: 909-13.
17. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
18. Costanza A, Weber K, Gandy S, Bouras C, Hof PR, Giannakopoulos G, et al. Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates. Neuropathol Appli Neurobiol 2011; 37: 570-84.
19. Corsellis JA, Brierley JB. Observations on the pathology of insidious dementia following head injury. J Ment Sci 1959; 105: 714-20.
20. Corsellis JA, Bruton CJ, Freeman-Browne D. The aftermath of boxing. Psychol Med 1973; 3: 270-303.
21. Critchley M. Punch-drunk syndromes: the chronic traumatic encepha-lopathy of boxers. In: Hommage à Clovis Vincent. Paris: Maloine, 1949.
22. Critchley M. Medical Aspects of Boxing, Particularly from a Neurological Standpoint. Br Med J 1957; 1: 357-62.
23. Daneshvar DH, Baugh CM, Nowinski CJ, McKee AC, Stern RA, Cantu RC. Helmets and mouth guards: the role of personal equipment in preventing sport-related concussions. Clin Sports Med 2011; 30: 145-63.
24. Daneshvar DH, Nowinski CJ, McKee AC, Cantu RC. The epidemiology of sport-related concussion. Clin Sports Med 2011; 30: 1-17.
25. De Calignon A, Polydoro M, Suá rez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012; 73: 685-97.
26. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002; 61: 413-26.
27. Dickson DW. Neuropathology of non-Alzheimer degenerative disorders. Int J Clin Exp Pathol 2009; 3: 1-23.
28. Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009; 284: 12845-52.
29. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, et al. The AD8: a brief informant interview to detect dementia. Neurology 2005; 65: 559-64.
30. Gandy S, Dekosky ST. APOE e4 status and traumatic brain injury on the gridiron or the battlefield. Sci Transl Med 2012; 4: 134ed4.
31. Gavett BE, Stern RA, Cantu RC, Nowinski CJ, McKee AC. Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimers Res Ther 2010; 2: 18.
32. Gavett BE, Stern RA, McKee AC. Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med 2011; 30: 179-88.
33. Geddes JF, Vowles GH, Nicoll JA, Revesz T. Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol 1999; 98: 171-8.
34. Genis L, Chen Y, Shohami E, Michaelson DM. Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury. J Neurosci Res 2000; 60: 559-64.
35. Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. Head injury and Parkinson's disease risk in twins. Ann Neurol 2006; 60: 65-72.
36. Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med 2012; 4: 134ra60.
37. Guo JL, Lee VM. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J. Biol Chem 2011; 286: 15317-31.
38. Hall GF, Patuto BA. Is tau now ready for admission to the Prion club? Prion 2012; 6: 223-233.
39. Hof PR, Knabe R, Bovier P, Bouras C. Neuropathological observations in a case of autism presenting with self-injury behaviour. Acta Neuropathol 1991; 82: 321-6.
40. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates csf flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid b. Sci Transl Med 2012; 4: 147 ra111.
41. Johan K, Westermark G, Engström U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95: 2558-63.
42. Kim WH, Lee S, Jung C, Ahmed A, Lee G, Hall GF. Interneuronal Transfer of Human Tau Between Lamprey Central Neurons in situ. J Alzheimer's Dis 2010; 19: 647-64.
43. Khlistunova I, Biernat J, Wang Y, Pickhardt M, von Bergen M, Gazova Z, et al. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J BiolChem 2006; 281: 1205-1214.
44. Lace G, Ince PG, Brayne C, Savva GM, Matthews FE, de Silva R, et al. Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort. Dement Geriatr Cogn Disord 2012; 3 (34): 15-24.
45. Liang Z, Liu F, Iqbal K, Grundke-Iqbal I, Gong C-X. Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage. J Alzheimers Dis 2009; 17: 531-9.
46. Litvan I, Hauw JJ, Bartko JJ, Lantos P, Daniel SE, Horoupian DS, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55: 97-105.
47. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012; 7: e31302.
48. López-González I, Carmona M, Blanco R, Luna-Munoz J, Martínez-Mandonado A, Mena R, et al. Characterization of thorn-shaped astro-cytes in white matter of temporal lobe in Alzheimer disease brains. Brain Pathol 2012, doi: 10.1111/j.1750-3639.2012.00627.x.
49. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of FTLD: an update. Acta Neuropathol 2010; 119: 1-4.
50. Martland HS. Punch Drunk. JAMA 1928; 91: 1103-7.
51. McKee AC, Au R, Cabral HJ, Kowall NW, Seshadri S, Kubilus C, et al. Visual association pathology in preclinical Alzheimer's disease. J Neuropath Exp Neurol 2006; 65: 621-30.
52. McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009; 68: 709-35.
53. McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010; 69: 918-29.
54. McKee AC, Kosik KS, Kowall NW. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol 1991; 30: 156-65.
55. McKee A, Montine T, Alvarez V, Schantz A, Steinbart E, Bird T. Distinctive patterns of tau and tdp-43 in a former professional football player and marine as compared to 3 siblings. J Neuropathol Exp Neurol 2011; 70 (6): 517.
56. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-24.
57. McKenzie JE, Roberts GW, Royston MC. Comparative investigation of neurofibrillary damage in the temporal lobe in Alzheimer's disease, Down's SYNDROME and dementia pugilistica. Neurodegeneration 1996; 5: 259-64.
58. McNair DM, Kahn RJ, Frankenthaler LM, Faldetta LL. Amoxapine and amitriptyline. II. Specificity of cognitive effects during brief treatment of depression. Psychopharmacology (Berl) 1984; 83: 134-9.
59. Millspaugh JA. Dementia pugilistica. US Naval Med Bulletin 1937; 35: 297-61.
60. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer's disease (CERAD): Part II standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86.
61. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123: 1-11.
62. Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, et al. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 2010; 30: 4528-35.
63. Morales R, Green KM, Soto C. Cross currents in protein misfolding disorders: interactions and therapy. CNS Neurol. Disord. Drug Targets 2009; 8: 363-71.
64. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 1999; 58: 1147-55.
65. Omalu BI, DeKosky ST, Hamilton RL, Minster RL, Kamboh MI, Shakir AM, et al. Chronic traumatic encephalopathy in a national football league player: part II. Neurosurgery 2006; 59: 1086-92; discussion 92-3.
66. Omalu BI, DeKosky ST, Minster RL, Kamboh MI, Hamilton RL, Wecht CH. Chronic traumatic encephalopathy in a national football league player. Neurosurgery 2005; 57: 128-34.
67. Omalu BI, Bailes J, Hammers JL, Fitzsimmons RP. Chronic traumatic en-cephalopathy, suicides and parasuicides in professional American athletes: the role of the forensic pathologist. Am J Forensic Med Pathol 2010; 31: 130-2.
68. Park S-Y, Ferreira A. The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates ß-Amyloid-Induced Neurodegeneration. J Neurosci 2005; 25: 5365-75.
69. Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982; 37: 323-9.
70. Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 2000; 55: 1158-66.
71. Pupillo E, Messina P, Logroscino G, Zoccolella S, Chiò A, Calvo A, et al. EURamyotrophic lateral sclerosis Consortium. Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. Eur J Neurol 2012. doi: 10.1111/j.1468-1331.2012.03723.x.
72. Saing T, Dick M, Nelson PT, Kim RC, Cribbs DH, Head E. Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma 2012; 29: 1054-70.
73. Schmidt ML, Zhukareva V, Newell KL, et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol 2001; 101: 518-24.
74. Schmidt S, Kwee LC, Allen KD, Oddone EZ. Association of amyotrophic lateral sclerosis with head injury, cigarette smoking and APOE genotypes. J Neurol Sci 2010; 291: 22-9.
75. Schoch KM, Evans HN, Brelsfoard JM, Madathil SK, Takano J, Saido TC, et al. Calpastatin overexpression limits calpain-mediated proteolysis and behavioural deficits following traumatic brain injury. Exp Neurol 2012; 236: 371-82.
76. Stern RA, Riley DO, Daneshvar DH, Nowinski CJ, Cantu RC, McKee AC. Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy. PMR 2011; 3: S460-7.
77. Tran HT, Sanchez L, Esparza TJ, Brody DL. Distinct temporal and anatomical distributions of amyloid-b and tau abnormalities following controlled cortical impact in transgenic mice. PLoS One 2011a; 6: e25475.
78. Tran HT, LaFerla FM, Holtzman DM, Brody DL. Controlled cortical impact traumatic brain injury in 3xTg-Alzheimer's disease mice causes acute intra-axonal amyloid-b accumulation and independently accelerates the development of tau abnormalities. J Neurosci 2011b; 31: 9513-25.
79. Vonsattel JPG, Aizawa H, Ge P, DiFiglia M, McKee AC, MacDonald M, et al. An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 1995; 54: 42-56.
80. Wilcock GK, Esiri MM. Plaques, tangles and dementia: a quantitative study. J Neurol Sci 1982; 56: 343-56.
81. Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, et al. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 2006; 580: 3582-8.